Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9542 |
High Similarity |
NPD7266 |
Discontinued |
0.8472 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8182 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7676 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7654 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7643 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7591 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7574 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7531 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7531 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7516 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7485 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7481 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7467 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7319 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7308 |
Intermediate Similarity |
NPD37 |
Approved |
0.7289 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7278 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7278 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7267 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7233 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7231 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7203 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7152 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD228 |
Approved |
0.7143 |
Intermediate Similarity |
NPD969 |
Suspended |
0.7133 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7121 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7121 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7086 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.708 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7024 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7023 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7021 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7014 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7006 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD8313 |
Approved |
0.6941 |
Remote Similarity |
NPD8312 |
Approved |
0.6929 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6929 |
Remote Similarity |
NPD5126 |
Approved |
0.6894 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6892 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6879 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6867 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6855 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6853 |
Remote Similarity |
NPD2983 |
Phase 2 |
0.6853 |
Remote Similarity |
NPD2982 |
Phase 2 |
0.6846 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6846 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6846 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6845 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6839 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD5058 |
Phase 3 |
0.6835 |
Remote Similarity |
NPD3687 |
Approved |
0.6835 |
Remote Similarity |
NPD3686 |
Approved |
0.6832 |
Remote Similarity |
NPD2977 |
Approved |
0.6832 |
Remote Similarity |
NPD2978 |
Approved |
0.6832 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6832 |
Remote Similarity |
NPD2801 |
Approved |
0.6831 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6824 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.681 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6809 |
Remote Similarity |
NPD9381 |
Approved |
0.6809 |
Remote Similarity |
NPD9384 |
Approved |
0.6807 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.68 |
Remote Similarity |
NPD6653 |
Approved |
0.6788 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6783 |
Remote Similarity |
NPD2981 |
Phase 2 |
0.6781 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6779 |
Remote Similarity |
NPD826 |
Approved |
0.6779 |
Remote Similarity |
NPD3620 |
Phase 2 |
0.6779 |
Remote Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.6779 |
Remote Similarity |
NPD825 |
Approved |
0.6776 |
Remote Similarity |
NPD9570 |
Approved |
0.6761 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6759 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6757 |
Remote Similarity |
NPD3764 |
Approved |
0.6748 |
Remote Similarity |
NPD3882 |
Suspended |
0.6738 |
Remote Similarity |
NPD9268 |
Approved |
0.6736 |
Remote Similarity |
NPD9622 |
Approved |
0.6733 |
Remote Similarity |
NPD447 |
Suspended |
0.6733 |
Remote Similarity |
NPD1933 |
Approved |
0.6722 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6715 |
Remote Similarity |
NPD7843 |
Approved |
0.671 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6691 |
Remote Similarity |
NPD7157 |
Approved |
0.6691 |
Remote Similarity |
NPD9280 |
Clinical (unspecified phase) |
0.669 |
Remote Similarity |
NPD4626 |
Approved |
0.6689 |
Remote Similarity |
NPD2492 |
Phase 1 |
0.6689 |
Remote Similarity |
NPD7095 |
Approved |
0.6688 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6688 |
Remote Similarity |
NPD1511 |
Approved |
0.6687 |
Remote Similarity |
NPD5402 |
Approved |
0.6686 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6686 |
Remote Similarity |
NPD6842 |
Approved |
0.6686 |
Remote Similarity |
NPD6841 |
Approved |
0.6667 |
Remote Similarity |
NPD3062 |
Approved |
0.6667 |
Remote Similarity |
NPD7680 |
Approved |
0.6667 |
Remote Similarity |
NPD3059 |
Approved |
0.6667 |
Remote Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD5736 |
Approved |
0.6667 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6667 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD3061 |
Approved |
0.6667 |
Remote Similarity |
NPD2684 |
Approved |
0.6667 |
Remote Similarity |
NPD5283 |
Phase 1 |
0.6647 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6646 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6646 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6645 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6645 |
Remote Similarity |
NPD4538 |
Approved |
0.6645 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.6645 |
Remote Similarity |
NPD4536 |
Approved |
0.6644 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6641 |
Remote Similarity |
NPD1242 |
Phase 1 |
0.6626 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6623 |
Remote Similarity |
NPD555 |
Phase 2 |
0.6623 |
Remote Similarity |
NPD5763 |
Approved |
0.6623 |
Remote Similarity |
NPD5762 |
Approved |
0.6622 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.662 |
Remote Similarity |
NPD5691 |
Approved |
0.6604 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6604 |
Remote Similarity |
NPD1512 |
Approved |
0.6603 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6603 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6603 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6599 |
Remote Similarity |
NPD9620 |
Approved |
0.6599 |
Remote Similarity |
NPD9621 |
Approved |
0.6599 |
Remote Similarity |
NPD9619 |
Approved |
0.6597 |
Remote Similarity |
NPD3092 |
Approved |
0.6593 |
Remote Similarity |
NPD290 |
Approved |
0.6588 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6585 |
Remote Similarity |
NPD5353 |
Approved |
0.6581 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6579 |
Remote Similarity |
NPD5314 |
Approved |
0.6573 |
Remote Similarity |
NPD1778 |
Approved |
0.6564 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6562 |
Remote Similarity |
NPD5403 |
Approved |
0.6556 |
Remote Similarity |
NPD4140 |
Approved |
0.6556 |
Remote Similarity |
NPD1558 |
Phase 1 |
0.6556 |
Remote Similarity |
NPD943 |
Approved |
0.6538 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6538 |
Remote Similarity |
NPD3060 |
Approved |
0.6538 |
Remote Similarity |
NPD4237 |
Approved |
0.6538 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6533 |
Remote Similarity |
NPD598 |
Approved |
0.6533 |
Remote Similarity |
NPD601 |
Approved |
0.6533 |
Remote Similarity |
NPD597 |
Approved |
0.6533 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6533 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6532 |
Remote Similarity |
NPD7038 |
Approved |
0.6532 |
Remote Similarity |
NPD7039 |
Approved |
0.6529 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6525 |
Remote Similarity |
NPD9493 |
Approved |
0.6525 |
Remote Similarity |
NPD694 |
Clinical (unspecified phase) |
0.6524 |
Remote Similarity |
NPD7819 |
Suspended |
0.6516 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6514 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6513 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6512 |
Remote Similarity |
NPD2934 |
Approved |
0.6512 |
Remote Similarity |
NPD2933 |
Approved |
0.6503 |
Remote Similarity |
NPD6385 |
Approved |
0.6503 |
Remote Similarity |
NPD6386 |
Approved |
0.6494 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6494 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6494 |
Remote Similarity |
NPD5588 |
Approved |
0.6494 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6494 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.649 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.649 |
Remote Similarity |
NPD1136 |
Approved |
0.649 |
Remote Similarity |
NPD1132 |
Approved |
0.649 |
Remote Similarity |
NPD259 |
Phase 1 |
0.649 |
Remote Similarity |
NPD6663 |
Approved |
0.649 |
Remote Similarity |
NPD1130 |
Approved |
0.6486
|
Remote Similarity |
NPD258 |
Approved |